Envoy Medical, Inc.
COCH
$1.38
$0.010.73%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 278.00K | 302.00K | 297.00K | 316.00K | 241.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 278.00K | 302.00K | 297.00K | 316.00K | 241.00K |
| Cost of Revenue | 819.00K | 821.00K | 738.00K | 760.00K | 677.00K |
| Gross Profit | -541.00K | -519.00K | -441.00K | -444.00K | -436.00K |
| SG&A Expenses | 10.16M | 9.50M | 9.64M | 8.94M | 6.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.75M | 20.18M | 19.80M | 18.69M | 14.78M |
| Operating Income | -21.47M | -19.88M | -19.50M | -18.37M | -14.54M |
| Income Before Tax | -21.06M | -13.54M | -22.83M | -29.82M | -36.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.06 | -13.54 | -22.83 | -29.82 | -36.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.06M | -13.54M | -22.83M | -29.82M | -36.41M |
| EBIT | -21.47M | -19.88M | -19.50M | -18.37M | -14.54M |
| EBITDA | -21.29M | -19.73M | -19.36M | -18.24M | -14.43M |
| EPS Basic | -1.28 | -0.77 | -1.81 | -2.73 | -3.62 |
| Normalized Basic EPS | -0.25 | -0.26 | -0.95 | -0.99 | -1.53 |
| EPS Diluted | -1.28 | -0.78 | -1.82 | -2.74 | -3.63 |
| Normalized Diluted EPS | -0.25 | -0.24 | -0.94 | -0.98 | -1.51 |
| Average Basic Shares Outstanding | 78.57M | 69.17M | 59.69M | 50.21M | 40.58M |
| Average Diluted Shares Outstanding | 78.57M | 70.17M | 60.69M | 51.21M | 41.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -8.70% | -- | -- | -- | -- |
